Adverum Biotechnologies, Inc

(NASDAQ:ADVM)

Latest On Adverum Biotechnologies, Inc (ADVM):

Date/Time Type Description Signal Details
2023-05-12 05:45 ESTNewsAdverum Biotechnologies GAAP EPS of -$0.29N/A
2023-03-31 16:31 ESTNewsAdverum Biotechnologies GAAP EPS of -$0.33 beats by $0.03N/A
2022-11-11 05:31 ESTNewsAdverum Biotechnologies GAAP EPS of -$0.40 misses by $0.06N/A
2022-08-11 22:16 ESTNewsAdverum Biotechnologies GAAP EPS of -$0.44 misses by $0.10N/A
2022-07-08 00:31 ESTNewsAdverum gains 13% to reach three-month high after Truist upgradeN/A
2022-06-10 10:03 ESTNewsAdverum wet AMD candidate ADVM-022 shows long-term benefit after single injectionN/A
2022-05-13 06:31 ESTNewsAdverum Biotechnologies GAAP EPS of -$0.38 misses by $0.07N/A
2022-04-07 03:30 ESTNewsAdverum gets FDA feedback on mid-stage trial for Wet AMD candidateN/A
2022-03-29 21:15 ESTNewsAdverum Biotechnologies GAAP EPS of -$0.35 misses by $0.01N/A
2022-02-07 17:00 ESTNewsAdverum Biotechnologies names new CMON/A
2022-01-03 15:46 ESTNewsAdverum granted FDA’s Orphan Drug Designation for treatment targeting color blindnessN/A
2021-11-05 00:15 ESTNewsAdverum Biotechnologies EPS misses by $0.01N/A
2021-10-02 05:31 ESTNewsAdverum posts promising two-year data for one-time injection in Wet AMDN/A
2021-10-02 05:31 ESTNewsADVM, SCPS, HX and NUVL among after hours moversN/A
2021-08-05 21:02 ESTNewsAdverum Biotechnologies EPS misses by $0.07N/A
2021-07-23 14:16 ESTNewsAdverum plunges as analysts turn bearish citing setback for diabetic macular edema drugN/A
2021-07-22 18:17 ESTNewsAdverum scraps development plans for ADVM-022 to treat diabetic macular edemaN/A
2021-07-20 17:43 ESTNewsAdverum President/CFO resigns, replacement namedN/A
2021-05-07 02:46 ESTNewsAdverum Biotechnologies EPS beats by $0.09, beats on revenueN/A
2021-05-06 06:34 ESTNewsAdverum Biotechnologies: An Uncertain Path ForwardN/A
2021-05-03 17:04 ESTNewsAdverum Bio presents long-term data from ADVM-022 trial in wet AMDN/A
2021-05-03 17:04 ESTNewsAdverum Biotechnologies: One Adverse Event Too ManyN/A
2021-05-03 17:03 ESTNewsTenet reinstated buy at Goldman Sachs, Adverum downgraded; in today’s healthcare analyst actionN/A
2021-04-30 05:05 ESTNewsAs Adverum plunges 62%, major shareholder calls for board changes (updated)N/A
2021-04-29 06:17 ESTNewsAdverum Biotechnologies provides update on ADVM-022 diabetic macular edema trialN/A
2021-03-26 04:01 ESTNewsAdverum Biotechnologies perks up after insider buyingN/A
2021-03-08 15:02 ESTAnalyst RatingThe Analyst Target Price has decreased from $25 to $24.89.Neutral
2021-03-04 15:02 ESTAnalyst RatingThe Analyst Target Price has decreased from $25.25 to $25.Neutral
2021-03-03 21:16 ESTNewsAdverum Biotechnologies, Inc. 2020 Q4 - Results - Earnings Call PresentationN/A
2021-03-03 15:02 ESTEarnings EstimateAn EPS average of -$1.82 is estimated for the 2022 year.Sell
2021-03-03 15:02 ESTEarnings EstimateAn EPS average of -$0.38 is estimated for the quarter ending on June 30, 2021.Buy
2021-03-03 15:02 ESTAnalyst RatingThe Analyst Target Price has decreased from $25.88 to $25.25.Neutral
2021-03-02 23:02 ESTFinancialsCompany financials have been released.Neutral
2021-03-02 07:16 ESTNewsAdverum Biotechnologies EPS misses by $0.06N/A
2021-03-02 07:16 ESTNewsAdverum Biotechnologies, Inc's (ADVM) CEO Laurent Fischer on Q4 2020 Results - Earnings Call TranscriptN/A
2021-02-19 04:46 ESTNewsAdverum Biotechnologies names new business chiefN/A
2021-02-12 11:02 ESTAnalyst RatingThe Analyst Target Price has increased from $25.22 to $25.88.Buy
2021-02-02 21:02 ESTNewsAdverum highlights preclinical long-term safety data on ADVM-022 IVT gene therapyN/A
2021-01-21 05:17 ESTNewsAdverum jumps 16% after insider transactionsN/A
2021-01-11 00:01 ESTNewsAdverum In Wet AMD And Diabetic Macular Edema: Playing In A Differentiated MarketN/A
2021-01-07 22:16 ESTNewsAdverum to invest $80M in new gene therapy manufacturing facilityN/A
2020-12-29 11:02 ESTAnalyst RatingThe Analyst Target Price has decreased from $26.75 to $25.22.Neutral
2020-12-13 03:03 ESTFinancialsCompany financials have been released.Neutral
2020-11-25 11:04 ESTFinancialsCompany financials have been released.Neutral
2020-11-16 15:01 ESTNewsAdverum ticks lower on underwhelming data from gene therapy in wet-AMDN/A
2020-11-10 19:03 ESTAnalyst RatingThe Analyst Target Price has decreased from $27 to $26.75.Neutral
2020-11-09 03:03 ESTFinancialsCompany financials have been released.Neutral
2020-11-08 23:02 ESTAnalyst RatingThe Analyst Target Price has decreased from $27.38 to $27.Neutral
2020-11-06 11:02 ESTEarnings EstimateAn EPS average of -$0.36 is estimated for the quarter ending on March 31, 2021.Sell
2020-11-06 01:16 ESTNewsAdverum Biotechnologies EPS beats by $0.04N/A

About Adverum Biotechnologies, Inc (ADVM):

Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal diseases, including wet age-related macular degeneration and diabetic macular edema. Adverum Biotechnologies, Inc. has license and collaboration agreements with University of California; Cornell University; GenSight; Lexeo; and Virovek. The company was formerly known as Avalanche Biotechnologies, Inc. and changed its name to Adverum Biotechnologies, Inc. in May 2016. Adverum Biotechnologies, Inc. was incorporated in 2006 and is headquartered in Redwood City, California.

See Advanced Chart

General

  • Name Adverum Biotechnologies, Inc
  • Symbol ADVM
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 167
  • Fiscal Year EndDecember
  • IPO Date2014-07-31
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.adverum.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 3419.85
  • Price/Book (Most Recent Quarter) 2.73
  • Enterprise Value Revenue 3700.64
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$1.68
  • Next Year EPS Estimate -$2.00
  • Next Quarter EPS Estimate -$0.31
  • Return on Assets -21%
  • Return on Equity -39%
  • Earnings Per Share -$1.05
  • Revenue Per Share $0
  • Gross Profit -73309000
  • Quarterly Earnings Growth -70%
View More

Highlights

  • Market Capitalization 1.01 billion
  • EBITDA -59744000
  • Analyst Target Price $24.89
  • Book Value Per Share $4.45
View More

Share Statistics

  • Shares Outstanding 97.8 million
  • Shares Float 61.93 million
  • % Held by Insiders 75%
  • % Held by Institutions 96.25%
  • Shares Short 10.05 million
  • Shares Short Prior Month 9.46 million
  • Short Ratio 14.75
  • Short % of Float 11%
  • Short % of Shares Outstanding 10%
View More

Technicals

  • Beta 1.49
  • 52 Week High $26.98
  • 52 Week Low $8.27
  • 50 Day Moving Average 12.45
  • 200 Day Moving Average 12.28
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Adverum Biotechnologies, Inc (ADVM) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Adverum Biotechnologies, Inc (ADVM) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-01$N/A-$0.39-$0.33-18.51%
2020-09-302020-11-05$N/A-$0.31-$0.3511.43%
2020-06-302020-08-10$N/A-$0.36-$0.29-23.58%
2020-03-312020-05-28$N/A-$0.31-$0.27-14.35%
2019-12-312020-03-12$N/A-$0.29-$0.302.26%
2019-09-302019-11-07$250000-$0.25-$0.265.41%
2019-06-302019-08-08$N/A-$0.23-$0.2713.21%
2019-03-312019-05-08$N/A-$0.23-$0.2714.18%
2018-12-312019-03-06$70000-$0.25-$0.2912.59%
2018-09-302018-11-08$833000-$0.34-$0.30-13.98%
2018-06-302018-08-08$493000-$0.30-$0.312.18%
2018-03-312018-05-09$216000-$0.30-$0.29-3.45%
2017-12-312018-03-06$461000-$0.32-$0.346.79%
2017-09-302017-11-08$463000-$0.32-$0.29-10.34%
2017-06-302017-08-08$463000-$0.27-$0.3316.92%
2017-03-312017-05-09$462000-$0.38-$0.26-46.15%
2016-12-312017-03-06$488000-$0.54-$0.30-78.04%
2016-09-302016-11-08$395000-$0.35-$0.29-19.33%
2016-06-302016-08-09$307000-$1.76-$0.33-441.54%
2016-03-312016-05-06$265000-$0.57-$0.29-96.55%
2015-12-312016-03-03$960000-$0.55-$0.40-36.37%
2015-09-302015-11-09$953000-$0.55-$0.42-30.95%
2015-06-302015-08-13$203000-$0.38-$0.392.56%
2015-03-312015-05-13$203000-$0.38-$0.405%
2014-12-312015-03-05$203000-$0.46-$0.29-58.62%
2014-09-302014-11-12$204000-$0.50-$0.21-138.1%
2014-06-302014-09-11$135000-$2.27

Adverum Biotechnologies, Inc (ADVM) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Adverum Biotechnologies, Inc (ADVM) Chart:

Adverum Biotechnologies, Inc (ADVM) News:

Below you will find a list of latest news for Adverum Biotechnologies, Inc (ADVM) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Adverum Biotechnologies, Inc (ADVM) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2024-05-1710CALL0 00TRUE00
2024-05-1720.25CALL0 20TRUE00
2024-05-1730.06CALL0 0661.4TRUE00
2024-05-1740CALL0 00TRUE00
2024-05-1750CALL0 0369.29TRUE00
2024-05-1760CALL0 0348.19TRUE00
2024-05-1778.6CALL0 1225.13TRUE00
2024-05-1780CALL0 0190.18TRUE00
2024-05-1791.9CALL50 200139.81TRUE1.90
2024-05-17101.2CALL23 160125.1TRUE0.20.2
2024-05-17110CALL0 0153.2FALSE00
2024-05-17120CALL0 0152.2FALSE00
2024-05-17130.31CALL0 6159.35FALSE00
2024-05-17140.6CALL0 40FALSE00
2024-05-17152.85CALL0 50FALSE00
2024-05-17160.15CALL0 60FALSE00
2024-05-17170CALL0 00FALSE00
2024-05-17181.35CALL0 200FALSE00
2024-05-17190.05CALL0 20FALSE00
2024-05-17200CALL0 00FALSE00
2024-05-17210CALL0 00FALSE00
2024-05-17220CALL0 00FALSE00
2024-05-17230CALL0 00FALSE00
2024-05-17240CALL0 00FALSE00
2024-05-17250.15CALL5 5272.68FALSE0.150
2024-05-17300CALL0 00FALSE00
2024-05-1710PUT0 00FALSE00
2024-05-1720PUT0 200FALSE00
2024-05-1730PUT0 00FALSE00
2024-05-1740PUT0 00FALSE00
2024-05-1750.09PUT0 30FALSE00
2024-05-1760.11PUT0 450FALSE00
2024-05-1770.15PUT0 510FALSE00
2024-05-1780PUT0 0168.97FALSE00
2024-05-1790.5PUT0 9114.02FALSE00
2024-05-17101.3PUT0 5141.48FALSE00
2024-05-17111.4PUT0 10121.15TRUE00
2024-05-17120PUT0 0145.41TRUE00
2024-05-17130PUT0 0239.18TRUE00
2024-05-17143.32PUT0 2261.8TRUE00
2024-05-17150PUT0 0280.48TRUE00
2024-05-17160PUT0 0208TRUE00
2024-05-17170PUT0 0226.19TRUE00
2024-05-17180PUT0 0232.39TRUE00
2024-05-17190PUT0 0304.68TRUE00
2024-05-17200PUT0 0375.6TRUE00
2024-05-17210PUT0 0367.24TRUE00
2024-05-17220PUT0 0396.63TRUE00
2024-05-17230PUT0 0320.94TRUE00
2024-05-17240PUT0 0296.55TRUE00
2024-05-17250PUT0 0342.86TRUE00
2024-05-17300PUT0 0364.64TRUE00
2024-06-2111.45CALL0 30TRUE00
2024-06-212.50.13CALL30 11490TRUE00
2024-06-2130CALL0 0678.08TRUE00
2024-06-2140.1CALL1 580TRUE00
2024-06-2150.1CALL0 0267.66TRUE00
2024-06-2160CALL0 0157.13TRUE00
2024-06-2170CALL0 0152.35TRUE00
2024-06-217.50.1CALL1 240TRUE00
2024-06-2180CALL0 0165.75TRUE00
2024-06-2192.5CALL0 1132.25TRUE00
2024-06-21101.65CALL0 11136.47TRUE00
2024-06-21110CALL0 0139.84FALSE00
2024-06-21120CALL0 0118.66FALSE00
2024-06-21130.8CALL0 100FALSE00
2024-06-21140.55CALL0 10118.87FALSE00
2024-06-21151.2CALL0 4141.06FALSE00
2024-06-21160CALL0 0129.37FALSE00
2024-06-21170CALL0 0147.69FALSE00
2024-06-21180CALL0 00FALSE00
2024-06-21190CALL0 0152.56FALSE00
2024-06-21200CALL0 00FALSE00
2024-06-21210CALL0 00FALSE00
2024-06-21220CALL0 00FALSE00
2024-06-21230CALL0 00FALSE00
2024-06-21240CALL0 00FALSE00
2024-06-21250CALL0 00FALSE00
2024-06-21300.2CALL0 50FALSE00
2024-06-2110.12PUT3 1500FALSE00
2024-06-212.50.85PUT1 20740FALSE00
2024-06-2130.05PUT0 100FALSE00
2024-06-2140PUT0 00FALSE00
2024-06-2150PUT0 0200.13FALSE00
2024-06-2160PUT0 0171.02FALSE00
2024-06-2170.52PUT0 3160.95FALSE00
2024-06-217.50PUT0 00FALSE00
2024-06-2181.05PUT0 1137.67FALSE00
2024-06-2191.22PUT0 4129.65FALSE00
2024-06-21101.92PUT0 2123.96FALSE00
2024-06-21110PUT0 0129.91TRUE00
2024-06-21123.4PUT0 3117.4TRUE00
2024-06-21130PUT0 0118.73TRUE00
2024-06-21140PUT0 0128.87TRUE00
2024-06-21150PUT0 0127.29TRUE00
2024-06-21160PUT0 0158.08TRUE00
2024-06-21170PUT0 0183.7TRUE00
2024-06-21180PUT0 0208.19TRUE00
2024-06-21190PUT0 0180.47TRUE00
2024-06-21200PUT0 0142.97TRUE00
2024-06-21219.4PUT0 1192.74TRUE00
2024-06-21220PUT0 0216.21TRUE00
2024-06-21230PUT0 0179.65TRUE00
2024-06-21240PUT0 0175.26TRUE00
2024-06-21250PUT0 0186.61TRUE00
2024-06-21300PUT0 0200.43TRUE00
2024-09-2011.05CALL2 30TRUE00
2024-09-202.50.3CALL14 7400TRUE00
2024-09-2030CALL0 0253.83TRUE00
2024-09-2040.12CALL1 410TRUE00
2024-09-2050.15CALL0 0195.92TRUE00
2024-09-2060CALL0 0172.88TRUE00
2024-09-2070CALL0 0132.03TRUE00
2024-09-207.50.1CALL30 310TRUE00
2024-09-2080CALL0 0121.61TRUE00
2024-09-2093CALL0 6118.62TRUE00
2024-09-20100CALL0 0123.32TRUE00
2024-09-20110CALL0 0121.32FALSE00
2024-09-20123CALL0 1120.74FALSE00
2024-09-20133.3CALL0 33117.72FALSE00
2024-09-20140CALL0 0119.29FALSE00
2024-09-20151.55CALL0 3114.83FALSE00
2024-09-20160CALL0 0122.16FALSE00
2024-09-20170CALL0 0116.74FALSE00
2024-09-20183.46CALL0 10119.6FALSE00
2024-09-20190CALL0 0123.99FALSE00
2024-09-20201.2CALL5 11123.69FALSE1.20
2024-09-20210CALL0 0125.03FALSE00
2024-09-20223CALL0 5123.68FALSE00
2024-09-20230.95CALL4 5125.33FALSE0.950
2024-09-20240CALL0 0124.24FALSE00
2024-09-20251CALL0 27122.67FALSE00
2024-09-20300.72CALL0 1126.05FALSE00
2024-09-2010.25PUT5 170FALSE00
2024-09-202.51PUT3 210FALSE00
2024-09-2030.35PUT0 440FALSE00
2024-09-2040PUT0 00FALSE00
2024-09-2050PUT0 0154.06FALSE00
2024-09-2060PUT0 0128.87FALSE00
2024-09-2071PUT0 5116.54FALSE00
2024-09-207.50PUT0 00FALSE00
2024-09-2080PUT0 0120.78FALSE00
2024-09-2090PUT0 0112.86FALSE00
2024-09-20100PUT0 0125.07FALSE00
2024-09-20110PUT0 0123.6TRUE00
2024-09-20120PUT0 0118.52TRUE00
2024-09-20130PUT0 0119.95TRUE00
2024-09-20140PUT0 0116.11TRUE00
2024-09-20150PUT0 0116.95TRUE00
2024-09-20160PUT0 0122.76TRUE00
2024-09-20170PUT0 0119.72TRUE00
2024-09-20180PUT0 0117.75TRUE00
2024-09-20190PUT0 0121.44TRUE00
2024-09-20200PUT0 0117.95TRUE00
2024-09-20210PUT0 0115.81TRUE00
2024-09-20220PUT0 0129.99TRUE00
2024-09-20230PUT0 0127.3TRUE00
2024-09-20240PUT0 0133.92TRUE00
2024-09-20250PUT0 0132.86TRUE00
2024-09-20300PUT0 0162.54TRUE00
2024-12-2040CALL0 0151.24TRUE00
2024-12-2050CALL0 0169.77TRUE00
2024-12-2060CALL0 0124.06TRUE00
2024-12-2070CALL0 0123.7TRUE00
2024-12-2080CALL0 0144.25TRUE00
2024-12-2090CALL0 0120.9TRUE00
2024-12-20100CALL0 0122.76TRUE00
2024-12-20113.18CALL0 1118.13FALSE00
2024-12-20120CALL0 0120.1FALSE00
2024-12-20130CALL0 0121.06FALSE00
2024-12-20140CALL0 0122.76FALSE00
2024-12-20150CALL0 0113.85FALSE00
2024-12-20162.28CALL0 25119.62FALSE00
2024-12-20170CALL0 0119.54FALSE00
2024-12-20180CALL0 0115.2FALSE00
2024-12-20190CALL0 0120.33FALSE00
2024-12-20201.68CALL0 1119.77FALSE00
2024-12-2040PUT0 0151.91FALSE00
2024-12-2050PUT0 0121.23FALSE00
2024-12-2060PUT0 0118.33FALSE00
2024-12-2070PUT0 0115.5FALSE00
2024-12-2080PUT0 0116FALSE00
2024-12-2090PUT0 0122.86FALSE00
2024-12-20100PUT0 0114.92FALSE00
2024-12-20110PUT0 0116.5TRUE00
2024-12-20120PUT0 0121.67TRUE00
2024-12-20130PUT0 0116.19TRUE00
2024-12-20140PUT0 0120.91TRUE00
2024-12-20150PUT0 0117.17TRUE00
2024-12-20160PUT0 0111.31TRUE00
2024-12-20170PUT0 0121.68TRUE00
2024-12-20180PUT0 0120.85TRUE00
2024-12-20190PUT0 0114.88TRUE00
2024-12-20200PUT0 0122.57TRUE00

Latest ADVM Trades:

Date Shares Price
Jun 13, 2022 7:58 PM EST800$0.952
Jun 13, 2022 7:58 PM EST100$0.952
Jun 13, 2022 7:59 PM EST13$0.951
Jun 13, 2022 7:59 PM EST8$0.951
Jun 13, 2022 7:59 PM EST33$0.951

Adverum Biotechnologies, Inc (ADVM) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312520182655/0001193125-20-182655-index.htm
2019-02-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1501756/000021545719006772/0000215457-19-006772-index.htm
2020-02-05SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1501756/000083423720004851/0000834237-20-004851-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1501756/000090266419000919/0000902664-19-000919-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1501756/000090266419001088/0000902664-19-001088-index.htm
2019-05-30SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1501756/000090266419002558/0000902664-19-002558-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1501756/000090266420000939/0000902664-20-000939-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1501756/000090266420001119/0000902664-20-001119-index.htm
2019-03-21SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1501756/000101359419000276/0001013594-19-000276-index.htm
2019-05-03SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1501756/000101359419000364/0001013594-19-000364-index.htm
2020-08-20SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1501756/000101359420000655/0001013594-20-000655-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1501756/000103738919000142/0001037389-19-000142-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1501756/000103738920000303/0001037389-20-000303-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1501756/000117266120000647/0001172661-20-000647-index.htm
2018-03-23S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1501756/000119312518094349/0001193125-18-094349-index.htm
2018-04-20DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1501756/000119312518124872/0001193125-18-124872-index.htm
2018-04-20DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1501756/000119312518124877/0001193125-18-124877-index.htm
2018-05-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312518150878/0001193125-18-150878-index.htm
2018-05-09DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1501756/000119312518157646/0001193125-18-157646-index.htm
2018-06-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312518181838/0001193125-18-181838-index.htm
2018-06-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312518194580/0001193125-18-194580-index.htm
2018-07-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312518211393/0001193125-18-211393-index.htm
2018-10-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312518301082/0001193125-18-301082-index.htm
2018-10-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312518306392/0001193125-18-306392-index.htm
2019-03-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312519060892/0001193125-19-060892-index.htm
2019-03-07S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1501756/000119312519067443/0001193125-19-067443-index.htm
2019-03-12S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1501756/000119312519071950/0001193125-19-071950-index.htm
2019-04-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312519117153/0001193125-19-117153-index.htm
2019-04-3010-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1501756/000119312519126512/0001193125-19-126512-index.htm
2019-05-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312519135105/0001193125-19-135105-index.htm
2019-06-17DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1501756/000119312519174714/0001193125-19-174714-index.htm
2019-06-17DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1501756/000119312519174720/0001193125-19-174720-index.htm
2019-07-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312519208871/0001193125-19-208871-index.htm
2019-08-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312519210860/0001193125-19-210860-index.htm
2019-08-08S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuershttps://www.sec.gov/Archives/edgar/data/1501756/000119312519216895/0001193125-19-216895-index.htm
2019-08-08S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1501756/000119312519216899/0001193125-19-216899-index.htm
2019-09-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312519240084/0001193125-19-240084-index.htm
2019-09-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312519243345/0001193125-19-243345-index.htm
2019-12-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312519314138/0001193125-19-314138-index.htm
2020-02-10424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1501756/000119312520029953/0001193125-20-029953-index.htm
2020-02-12424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1501756/000119312520033298/0001193125-20-033298-index.htm
2020-02-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312520033345/0001193125-20-033345-index.htm
2020-03-12S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1501756/000119312520071731/0001193125-20-071731-index.htm
2020-04-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312520112176/0001193125-20-112176-index.htm
2020-04-28DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1501756/000119312520123125/0001193125-20-123125-index.htm
2020-04-28DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1501756/000119312520123159/0001193125-20-123159-index.htm
2020-06-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312520169353/0001193125-20-169353-index.htm
2020-06-19DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1501756/000119312520174007/0001193125-20-174007-index.htm
2020-06-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312520182655/0001193125-20-182655-index.htm
2020-08-10S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1501756/000119312520215063/0001193125-20-215063-index.htm
2020-08-12424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1501756/000119312520216586/0001193125-20-216586-index.htm
2020-08-13424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1501756/000119312520219223/0001193125-20-219223-index.htm
2020-08-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000119312520219248/0001193125-20-219248-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919118038052/0001209191-18-038052-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919118038054/0001209191-18-038054-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919118038055/0001209191-18-038055-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919118038058/0001209191-18-038058-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919118038066/0001209191-18-038066-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919118038086/0001209191-18-038086-index.htm
2018-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919118038333/0001209191-18-038333-index.htm
2018-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919118038335/0001209191-18-038335-index.htm
2018-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919118038336/0001209191-18-038336-index.htm
2018-10-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919118055834/0001209191-18-055834-index.htm
2019-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119011063/0001209191-19-011063-index.htm
2019-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119011066/0001209191-19-011066-index.htm
2019-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119011069/0001209191-19-011069-index.htm
2019-04-023Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119022581/0001209191-19-022581-index.htm
2019-04-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119022603/0001209191-19-022603-index.htm
2019-04-253Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119026003/0001209191-19-026003-index.htm
2019-04-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119026004/0001209191-19-026004-index.htm
2019-05-033Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119027386/0001209191-19-027386-index.htm
2019-05-033Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119027389/0001209191-19-027389-index.htm
2019-05-033Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119027391/0001209191-19-027391-index.htm
2019-05-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119027395/0001209191-19-027395-index.htm
2019-05-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119027396/0001209191-19-027396-index.htm
2019-05-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119027398/0001209191-19-027398-index.htm
2019-05-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119027832/0001209191-19-027832-index.htm
2019-08-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119044245/0001209191-19-044245-index.htm
2019-08-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119044247/0001209191-19-044247-index.htm
2019-08-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119044249/0001209191-19-044249-index.htm
2019-08-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119044251/0001209191-19-044251-index.htm
2019-08-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119044254/0001209191-19-044254-index.htm
2019-08-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119044256/0001209191-19-044256-index.htm
2019-08-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119044258/0001209191-19-044258-index.htm
2019-08-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119044260/0001209191-19-044260-index.htm
2019-08-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119046306/0001209191-19-046306-index.htm
2019-08-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119046311/0001209191-19-046311-index.htm
2019-08-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119046313/0001209191-19-046313-index.htm
2019-10-254/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119054092/0001209191-19-054092-index.htm
2019-11-013Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119054741/0001209191-19-054741-index.htm
2019-11-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119054742/0001209191-19-054742-index.htm
2019-12-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919119061950/0001209191-19-061950-index.htm
2020-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120001014/0001209191-20-001014-index.htm
2020-02-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120007754/0001209191-20-007754-index.htm
2020-02-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120007755/0001209191-20-007755-index.htm
2020-02-104/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120007756/0001209191-20-007756-index.htm
2020-02-104/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120007757/0001209191-20-007757-index.htm
2020-02-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120007758/0001209191-20-007758-index.htm
2020-02-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120007759/0001209191-20-007759-index.htm
2020-02-144/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120009846/0001209191-20-009846-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120009847/0001209191-20-009847-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120009848/0001209191-20-009848-index.htm
2020-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120011155/0001209191-20-011155-index.htm
2020-02-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120011783/0001209191-20-011783-index.htm
2020-02-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120011785/0001209191-20-011785-index.htm
2020-02-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120011787/0001209191-20-011787-index.htm
2020-02-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120011789/0001209191-20-011789-index.htm
2020-02-253Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120012797/0001209191-20-012797-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120012798/0001209191-20-012798-index.htm
2020-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120020107/0001209191-20-020107-index.htm
2020-03-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120021159/0001209191-20-021159-index.htm
2020-04-203Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120025153/0001209191-20-025153-index.htm
2020-04-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120025154/0001209191-20-025154-index.htm
2020-05-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120027287/0001209191-20-027287-index.htm
2020-05-084/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120028067/0001209191-20-028067-index.htm
2020-05-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120028070/0001209191-20-028070-index.htm
2020-05-204/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120031045/0001209191-20-031045-index.htm
2020-05-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120031047/0001209191-20-031047-index.htm
2020-05-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120031872/0001209191-20-031872-index.htm
2020-06-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120037330/0001209191-20-037330-index.htm
2020-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120037335/0001209191-20-037335-index.htm
2020-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120037339/0001209191-20-037339-index.htm
2020-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120037369/0001209191-20-037369-index.htm
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120037769/0001209191-20-037769-index.htm
2020-06-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120038635/0001209191-20-038635-index.htm
2020-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120038958/0001209191-20-038958-index.htm
2020-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120038959/0001209191-20-038959-index.htm
2020-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120038960/0001209191-20-038960-index.htm
2020-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120038962/0001209191-20-038962-index.htm
2020-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120038963/0001209191-20-038963-index.htm
2020-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120038964/0001209191-20-038964-index.htm
2020-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120038966/0001209191-20-038966-index.htm
2020-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120038967/0001209191-20-038967-index.htm
2020-07-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120043426/0001209191-20-043426-index.htm
2020-08-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120047622/0001209191-20-047622-index.htm
2020-08-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501756/000120919120047624/0001209191-20-047624-index.htm
2018-11-16SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1501756/000149315218016327/0001493152-18-016327-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1501756/000149315219001941/0001493152-19-001941-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1501756/000149315220002379/0001493152-20-002379-index.htm
2018-05-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1501756/000156459018012437/0001564590-18-012437-index.htm
2018-08-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1501756/000156459018020510/0001564590-18-020510-index.htm
2018-11-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1501756/000156459018028654/0001564590-18-028654-index.htm
2019-03-0610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1501756/000156459019006536/0001564590-19-006536-index.htm
2019-05-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1501756/000156459019017203/0001564590-19-017203-index.htm
2019-08-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1501756/000156459019030765/0001564590-19-030765-index.htm
2019-11-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1501756/000156459019041787/0001564590-19-041787-index.htm
2020-03-1210-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1501756/000156459020010503/0001564590-20-010503-index.htm
2020-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000162828020007251/0001628280-20-007251-index.htm
2020-05-2810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1501756/000162828020008534/0001628280-20-008534-index.htm
2020-08-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000162828020012330/0001628280-20-012330-index.htm
2020-08-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1501756/000162828020012332/0001628280-20-012332-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501756/000162828020015738/0001628280-20-015738-index.htm
2020-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1501756/000162828020015761/0001628280-20-015761-index.htm
2018-04-16CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1501756/999999999718004871/9999999997-18-004871-index.htm
2019-03-19CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1501756/999999999719001422/9999999997-19-001422-index.htm
2020-06-24CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1501756/999999999720003738/9999999997-20-003738-index.htm

Adverum Biotechnologies, Inc (ADVM) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Adverum Biotechnologies, Inc (ADVM). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 75%
Institutional Ownership: 9625%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-08-17Peter SoparkarChief Legal OfficerBuy7,692.0013.0099,996.0010,692.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120047624/0001209191-20-047624-index.htm
2020-06-16LEONE D PATTERSONPresidentSell13,171.0024.68325,060.28110,488.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120037369/0001209191-20-037369-index.htm
2018-06-15Jennifer C. ChengGeneral CounselBuy11,150.00118,863.00https://www.sec.gov/Archives/edgar/data/1501756/000120919118038335/0001209191-18-038335-index.htm
2020-03-20LEONE D PATTERSONCEO, President and DirectorSell39,526.0010.17401,908.27123,429.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120021159/0001209191-20-021159-index.htm
2020-05-06LEONE D PATTERSONCEO, President and DirectorSell20,000.0020.02400,400.00123,659.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120028070/0001209191-20-028070-index.htm
2020-03-17LEONE D PATTERSONCEO, President and DirectorSell474.0010.024,749.24138,531.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120020107/0001209191-20-020107-index.htm
2020-05-06LEONE D PATTERSONCEO, President and DirectorBuy20,000.003.4468,800.00143,659.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120028070/0001209191-20-028070-index.htm
2020-03-20LEONE D PATTERSONCEO, President and DirectorBuy24,424.003.4484,018.56162,955.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120021159/0001209191-20-021159-index.htm
2019-05-06James Paul ScopaDirectorBuy20,000.006.71134,200.0020,000.00https://www.sec.gov/Archives/edgar/data/1501756/000120919119027832/0001209191-19-027832-index.htm
2019-12-23LEONE D PATTERSONCEO, President and DirectorSell40,000.0010.72428,800.00228,496.00https://www.sec.gov/Archives/edgar/data/1501756/000120919119061950/0001209191-19-061950-index.htm
2020-02-12Mehdi GasmiDirectorSell10,000.0015.07150,690.00258,979.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120009847/0001209191-20-009847-index.htm
2020-02-18Mehdi GasmiDirectorSell5,000.0016.2381,156.00258,979.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120011155/0001209191-20-011155-index.htm
2020-02-18Mehdi GasmiDirectorBuy5,000.004.8024,000.00263,979.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120011155/0001209191-20-011155-index.htm
2018-06-15LEONE D PATTERSONSVP, CFO, Interim Pres and CEOBuy88,496.00268,496.00https://www.sec.gov/Archives/edgar/data/1501756/000120919118038333/0001209191-18-038333-index.htm
2020-02-12Mehdi GasmiDirectorBuy10,000.004.8048,000.00268,979.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120009847/0001209191-20-009847-index.htm
2020-05-05Mehdi GasmiDirectorSell10,000.0016.26162,573.00274,442.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120031047/0001209191-20-031047-index.htm
2020-05-06Mehdi GasmiDirectorSell25,000.0020.03500,667.50274,442.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120031047/0001209191-20-031047-index.htm
2020-05-18Mehdi GasmiDirectorSell300.0019.035,709.00274,442.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120031047/0001209191-20-031047-index.htm
2020-05-20Mehdi GasmiDirectorSell1,401.0020.0128,029.95274,442.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120031872/0001209191-20-031872-index.htm
2020-05-21Mehdi GasmiDirectorSell3,599.0020.0272,048.02274,442.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120031872/0001209191-20-031872-index.htm
2020-06-15Mehdi GasmiDirectorSell159.0023.593,751.18274,442.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120037339/0001209191-20-037339-index.htm
2020-06-17Mehdi GasmiDirectorSell268.0025.016,702.71274,442.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120037769/0001209191-20-037769-index.htm
2020-06-18Mehdi GasmiDirectorSell11,127.0025.01278,328.55274,442.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120037769/0001209191-20-037769-index.htm
2020-06-22Mehdi GasmiDirectorSell23,605.0025.06591,616.84274,442.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120038635/0001209191-20-038635-index.htm
2020-07-20Mehdi GasmiDirectorSell5,000.0017.6087,978.00274,442.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120043426/0001209191-20-043426-index.htm
2020-06-15Mehdi GasmiDirectorSell3,425.0023.0078,786.65274,601.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120037339/0001209191-20-037339-index.htm
2020-06-17Mehdi GasmiDirectorBuy268.004.801,286.40274,710.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120037769/0001209191-20-037769-index.htm
2020-05-18Mehdi GasmiDirectorSell4,700.0018.1185,124.05274,742.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120031047/0001209191-20-031047-index.htm
2020-05-20Mehdi GasmiDirectorBuy1,401.004.806,724.80275,843.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120031872/0001209191-20-031872-index.htm
2020-06-15Mehdi GasmiDirectorSell1,416.0021.9331,047.07278,026.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120037339/0001209191-20-037339-index.htm
2020-05-21Mehdi GasmiDirectorBuy3,599.004.8017,275.20278,041.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120031872/0001209191-20-031872-index.htm
2020-05-18Mehdi GasmiDirectorBuy5,000.004.8024,000.00279,442.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120031047/0001209191-20-031047-index.htm
2020-07-20Mehdi GasmiDirectorBuy5,000.004.8024,000.00279,442.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120043426/0001209191-20-043426-index.htm
2020-06-15Mehdi GasmiDirectorSell5,000.0021.01105,042.00279,442.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120037339/0001209191-20-037339-index.htm
2020-05-05Mehdi GasmiDirectorBuy10,000.004.8048,000.00284,442.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120031047/0001209191-20-031047-index.htm
2020-06-15Mehdi GasmiDirectorBuy10,000.004.8048,000.00284,442.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120037339/0001209191-20-037339-index.htm
2020-06-18Mehdi GasmiDirectorBuy11,127.004.8053,409.60285,569.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120037769/0001209191-20-037769-index.htm
2020-06-22Mehdi GasmiDirectorBuy23,605.004.80113,304.00298,047.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120038635/0001209191-20-038635-index.htm
2020-05-06Mehdi GasmiDirectorBuy25,000.004.80120,000.00299,442.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120031047/0001209191-20-031047-index.htm
2020-02-14James Paul ScopaDirectorBuy10,000.0013.75137,500.0030,000.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120009848/0001209191-20-009848-index.htm
2020-01-15Mehdi GasmiDirectorBuy88,496.00321,418.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120009847/0001209191-20-009847-index.htm
2018-06-15Mehdi GasmiChief Science & Tech OfficerBuy88,496.00387,031.00https://www.sec.gov/Archives/edgar/data/1501756/000120919118038336/0001209191-18-038336-index.htm
2020-05-04James Paul ScopaDirectorBuy23,334.006.48151,204.3253,334.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120027287/0001209191-20-027287-index.htm
2020-08-17Laurent FischerCEO and DirectorBuy7,692.0013.0099,996.007,692.00https://www.sec.gov/Archives/edgar/data/1501756/000120919120047622/0001209191-20-047622-index.htm